Cargando…

A Review of Special Considerations on Insulin Resistance Induced Hyperandrogenemia in Women with Polycystic Ovary Syndrome: A Prominent COVID-19 Risk Factor

Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) infecting mechanism depends on hosting angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2) as essential components and androgens as regulators for inducing the expression of these components. Therefore, hy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roozbeh, Jamshid, Janfeshan, Sahar, Afshari, Afsoon, Doostkam, Aida, Yaghobi, Ramin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Babol University of Medical Sciences 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116349/ https://www.ncbi.nlm.nih.gov/pubmed/37091038 http://dx.doi.org/10.22088/IJMCM.BUMS.11.2.168

Ejemplares similares

Covid-19 pathogenesis in prostatic cancer and TMPRSS2-ERG regulatory genetic pathway
por: Afshari, Afsoon, et al.
Publicado: (2021)

Sialic acid: an attractive biomarker with promising biomedical applications
por: Doostkam, Aida, et al.
Publicado: (2022)

Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications
por: López-Alarcón, Mardia, et al.
Publicado: (2023)

Metastatin as a Marker for Hyperandrogenemia in Iraqi Women with Polycystic Ovary Syndrome
por: Abdalqader, Manal Madany, et al.
Publicado: (2020)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

The effect of BKV reactivation on cytokines behavior in kidney transplanted patients
por: Rahimi, Zahra, et al.
Publicado: (2022)

Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
por: O'Reilly, Michael W., et al.
Publicado: (2014)

Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype
por: Lerchbaum, Elisabeth, et al.
Publicado: (2014)

Relationship between nonalcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome
por: Kara, Ozlem, et al.
Publicado: (2023)

Inter-regulatory role of microRNAs in interaction between viruses and stem cells
por: Afshari, Afsoon, et al.
Publicado: (2021)

Cytomegalovirus microRNAs level determination in kidney recipients post transplantation
por: Afshari, Afsoon, et al.
Publicado: (2022)

Embryos from polycystic ovary syndrome patients with hyperandrogenemia reach morula stage faster than controls
por: Chappell, Neil Ryan, et al.
Publicado: (2020)

Single-Cell RNA-Seq Identifies Pathways and Genes Contributing to the Hyperandrogenemia Associated with Polycystic Ovary Syndrome
por: Harris, R. Alan, et al.
Publicado: (2023)

Sensitive and specific markers for insulin resistance, hyperandrogenemia, and inappropriate gonadotrophin secretion in women with polycystic ovary syndrome: a case-control study from Bahrain
por: Golbahar, Jamal, et al.
Publicado: (2012)

Low Serum 25-Hydroxyvitamin D Levels Are Associated With Hyperandrogenemia in Polycystic Ovary Syndrome: A Cross-Sectional Study
por: Shan, Chang, et al.
Publicado: (2022)

Alterations in MicroRNA gene expression profile in liver transplant patients with hepatocellular carcinoma
por: Afshari, Afsoon, et al.
Publicado: (2021)

Determination of insulin resistance and its relationship with hyperandrogenemia,anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome
por: YETİM ŞAHİN, Aylin, et al.
Publicado: (2019)

Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia—A New Insight on Syndrome Pathogenesis
por: Ozegowska, Katarzyna, et al.
Publicado: (2020)

OR15-3 Contribution of Hyperandrogenemia to Dysbiosis, Gut Inflammation, and Dysregulation of Short-Chain Fatty Acid Homeostasis in Mouse Model of Polycystic Ovary Syndrome
por: Alsemeh, Amira, et al.
Publicado: (2022)

Diagnosis of Sertoli-Leydig Cell Tumor of the Ovary Complicated by the Pattern of Hyperandrogenemia and Results of Imaging
por: Jaju, Amruta, et al.
Publicado: (2021)

Postmenopausal women with hyperandrogenemia: Three case reports
por: Zhu, Xiao-Dan, et al.
Publicado: (2021)

Adrenal myelolipoma with hyperandrogenemia and schizophrenia
por: Liu, Ningning, et al.
Publicado: (2018)

Postmenopausal mild hirsutism and hyperandrogenemia due to granulosa cell tumor of the ovary: a case report
por: Adefris, Mulat, et al.
Publicado: (2017)

Comparison between olfactory training and curcumin therapy in improving olfactory dysfunction in patients with chronic kidney disease
por: Malekmakan, Leila, et al.
Publicado: (2023)

Association between polycystic ovarian morphology and insulin resistance in women with polycystic ovary syndrome
por: Lee, Jeong Eun, et al.
Publicado: (2023)

Markers of insulin resistance in Polycystic ovary syndrome women: An update
por: Amisi, Chantal Anifa
Publicado: (2022)

Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome
por: Hwang, Kyu Ri, et al.
Publicado: (2013)

Insulin resistance and fertility in polycystic ovary syndrome.
por: Fica, S, et al.
Publicado: (2008)

Hyperandrogenemia due to ingestion of Butea superba
por: Chaiyasit, Kamon, et al.
Publicado: (2012)

The impact of obesity on hyperandrogenemia in Korean girls
por: Kang, Min Jae, et al.
Publicado: (2016)

Risk of Insulin Resistance and Metabolic Syndrome in Women with Hyperandrogenemia: A Comparison between PCOS Phenotypes and Beyond
por: Borzan, Valentin, et al.
Publicado: (2021)

Antithyroid peroxidase antibodies in women with polycystic ovary syndrome
por: Salehpour, Saghar, et al.
Publicado: (2013)

The relation of dermcidin with insulin resistance and inflammation in women with polycystic ovary syndrome
por: Akan, Ozden Yildirim, et al.
Publicado: (2022)

Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue
por: Zhang, Yahui, et al.
Publicado: (2023)

The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women
por: Valderhaug, T.G., et al.
Publicado: (2015)

Association of MicroRNA Polymorphisms With Hepatocellular Carcinoma in an Iranian Population
por: Farokhizadeh, Zhaleh, et al.
Publicado: (2019)

New markers of insulin resistance in polycystic ovary syndrome
por: Polak, K., et al.
Publicado: (2016)

Limitations of insulin resistance assessment in polycystic ovary syndrome
por: Lewandowski, Krzysztof C, et al.
Publicado: (2018)

Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology
por: Dadachanji, Roshan, et al.
Publicado: (2018)

Cardiometabolic consequences of maternal hyperandrogenemia in male offspring
por: Zuchowski, Yvonne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l2kptmrsn7p1pna5gi07hn9mgm